166 related articles for article (PubMed ID: 18633273)
1. [A case of brain metastasis from advanced ovarian clear-cell carcinoma during maintenance chemotherapy with irinotecan+cisplatin].
Takami M; Kita E; Kuwana Y; Ohta Y; Nakayama Y; Fukai H; Matsumoto H; Takimoto T; Ichikawa G; Yamamoto T
Gan To Kagaku Ryoho; 2008 Jul; 35(7):1243-5. PubMed ID: 18633273
[TBL] [Abstract][Full Text] [Related]
2. [Successful optimal debulking surgery following chemotherapy combined with irinotecan hydrochloride and cisplatin for advanced clear cell carcinoma of the ovary].
Hirakawa H; Futagami M; Yokoyama Y; Hakamada K; Mizunuma H
Gan To Kagaku Ryoho; 2011 May; 38(5):857-60. PubMed ID: 21566454
[TBL] [Abstract][Full Text] [Related]
3. Complete response to irinotecan hydrochloride and nedaplatin in a patient with advanced ovarian clear cell carcinoma.
Nishida M; Tsunoda H; Ichikawa Y; Yoshikawa H
Int J Clin Oncol; 2004 Oct; 9(5):403-5. PubMed ID: 15549593
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage I ovarian clear cell carcinoma.
Ho CM; Chien TY; Shih BY; Huang SH
Gynecol Oncol; 2003 Mar; 88(3):394-9. PubMed ID: 12648592
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic analysis of 88 patients with ovarian clear cell carcinoma].
Ma SK; Zhang HT; Wu LY; Liu LY
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):784-8. PubMed ID: 18396695
[TBL] [Abstract][Full Text] [Related]
6. Irinotecan hydrochloride (CPT-11) and cisplatin as first-line chemotherapy after initial surgery for ovarian clear cell adenocarcinoma.
Takakura S; Saito M; Ueda K; Motegi M; Takao M; Yamada K; Okamoto A; Niimi S; Sasaki H; Tanaka T; Ochiai K
Int Surg; 2007; 92(4):202-8. PubMed ID: 18050828
[TBL] [Abstract][Full Text] [Related]
7. Progression-free survival and overall survival of patients with clear cell carcinoma of the ovary treated with paclitaxel-carboplatin or irinotecan-cisplatin: retrospective analysis.
Takano M; Sugiyama T; Yaegashi N; Suzuki M; Tsuda H; Sagae S; Udagawa Y; Kuzuya K; Kigawa J; Takeuchi S; Tsuda H; Moriya T; Kikuchi Y
Int J Clin Oncol; 2007 Aug; 12(4):256-60. PubMed ID: 17701003
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy with irinotecan hydrochloride and cisplatin for clear cell carcinoma of the ovary.
Takano M; Kikuchi Y; Yaegashi N; Suzuki M; Tsuda H; Sagae S; Udagawa Y; Kuzuya K; Kigawa J; Takeuchi S; Tsuda H; Moriya T; Sugiyama T
Oncol Rep; 2006 Dec; 16(6):1301-6. PubMed ID: 17089053
[TBL] [Abstract][Full Text] [Related]
9. [A case of advanced ovarian carcinosarcoma that responded remarkably to neoadjuvant chemotherapy of combined CPT-11 and CDDP].
Takami M; Idei T; Nakayama Y; Ohta H; Fukai H; Matsumoto H; Togo Y; Sakamoto H; Yamamoto T; Satoh K
Gan To Kagaku Ryoho; 2002 Feb; 29(2):305-8. PubMed ID: 11865639
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival in patients with clear cell adenocarcinoma of ovary treated with irinotecan hydrochloride plus cisplatin therapy as first-line chemotherapy.
Kunito S; Takakura S; Nagata C; Saito M; Yanaihara N; Yamada K; Okamoto A; Sasaki H; Ochiai K; Tanaka T
J Obstet Gynaecol Res; 2012 Dec; 38(12):1367-75. PubMed ID: 22639843
[TBL] [Abstract][Full Text] [Related]
11. Irinotecan hydrochloride (CPT-11) and mitomycin C as the first line chemotherapy for ovarian clear cell adenocarcinoma.
Nishino K; Aoki Y; Amikura T; Obata H; Sekine M; Yahata T; Fujita K; Tanaka K
Gynecol Oncol; 2005 Jun; 97(3):893-7. PubMed ID: 15894369
[TBL] [Abstract][Full Text] [Related]
12. Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease.
Ho CM; Huang YJ; Chen TC; Huang SH; Liu FS; Chang Chien CC; Yu MH; Mao TL; Wang TY; Hsieh CY
Gynecol Oncol; 2004 Jul; 94(1):197-203. PubMed ID: 15262142
[TBL] [Abstract][Full Text] [Related]
13. [A case of platinum-resistant, recurrent ovarian clear cell adenocarcinoma successfully treated with irinotecan (CPT-11) and paclitaxel (PTX) chemotherapy].
Konishi H; Takehara K; Okame S; Yamamoto Y; Kojima A; Shiroyama Y; Yokoyama T; Nogawa T
Gan To Kagaku Ryoho; 2014 Nov; 41(11):1437-9. PubMed ID: 25434451
[TBL] [Abstract][Full Text] [Related]
14. Complete remission of ovarian small cell carcinoma treated with irinotecan and cisplatin: a case report.
Saitoh-Sekiguchi M; Nakahara K; Kojimahara T; Ohta T; Kawagoe J; Ohnuki T; Hayasaka T; Motoyama T; Kurachi H
Anticancer Res; 2007; 27(4C):2685-7. PubMed ID: 17695433
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of chemotherapy for clear cell adenocarcinoma of the ovary].
Okubo T; Takeda S; Ikeba K; Takagi Y; Ishihara O; Seki H; Kinoshita K
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1279-83. PubMed ID: 9279347
[TBL] [Abstract][Full Text] [Related]
16. [Combination of irinotecan hydrochloride (CPT-11) and cisplatin as a new regimen for patients with advanced ovarian cancer].
Sugiyama T; Nishida T; Kataoka A; Imaishi K; Komai K; Ushijima K; Hasuo Y; Ookura N; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Sep; 48(9):827-34. PubMed ID: 8841050
[TBL] [Abstract][Full Text] [Related]
17. [Paclitaxel + carboplatin (TC)-resistant stage Ic squamous cell carcinomas arising in mature cystic teratomas of the ovary].
Ishikawa M; Nakayama K; Yeasmin S; Katagiri A; Iida K; Nakayama N; Miyazaki K
Gan To Kagaku Ryoho; 2010 Apr; 37(4):747-52. PubMed ID: 20414041
[TBL] [Abstract][Full Text] [Related]
18. A pilot study of CPT-11 and cisplatin for ovarian clear cell adenocarcinoma.
Adachi S; Ogasawara T; Yamasaki N; Shibahara H; Kanazawa R; Tsuji Y; Takemura T; Koyama K
Jpn J Clin Oncol; 1999 Sep; 29(9):434-7. PubMed ID: 10563197
[TBL] [Abstract][Full Text] [Related]
19. [A case of solitary metastatic splenic tumor of ovarian carcinoma].
Kobayashi A; Yamaguchi M; Koarai N; Sugizaki N
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1341-5. PubMed ID: 9279357
[TBL] [Abstract][Full Text] [Related]
20. [A case of advanced ovarian clear cell adenocarcinoma responding to cisplatin-cyclophosphamide and paclitaxel-carboplatin].
Iwasaki K; Komuro Y; Masumoto N; Asaoka K; Ishitani K
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1483-6. PubMed ID: 10500539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
